Evidence map›Paper›PMID 42011133›Full record

ArticleChembiochem : a European journal of chemical biology2026

Biocatalytic Indigo Synthesis From L-Tryptophan Using a Three-Step Cascade Without Cofactor Regeneration.

Vivian P Willers, Nikola Lončar, Marco W Fraaije

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vivian P WillersMolecular Enzymology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-1160-3478
Nikola LončarGECCO Biotech, Groningen, The Netherlands.ORCID 0000-0002-3420-973X
Marco W FraaijeMolecular Enzymology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-6346-5014

Funding

Eurostars Project ID 3856 (OXYMEL)
6 · The paper itself

Abstract

Indigo is currently produced from petrochemical sources, which poses significant environmental challenges. Sustainable biotechnological alternatives are therefore highly desirable. Enzymatic synthesis of indigo from L-tryptophan via indole has been demonstrated, but conventional pathways based on flavin-containing monooxygenases require costly coenzymes such as NAD(P)H, limiting their practical applicability. In this study, we present a novel, self-sufficient, NAD(P)H-independent enzyme cascade for indigo biosynthesis from the renewable feedstock L-tryptophan. The cascade starts with conversion of L-tryptophan into indole and pyruvate by a tryptophanase. As next steps, the system couples an engineered bacterial tyrosine hydroxylase, which converts indole into indoxyl using hydrogen peroxide, with a pyruvate oxidase that generates the required peroxide in situ. The cascade thereby transforms a reaction byproduct into the oxidizing equivalent needed for the subsequent step, establishing a closed catalytic cycle with minimal auxiliary inputs. After optimizing cascade parameters, the system produced 0.25 mM indigo from 5 mM L-tryptophan. Although the overall yield remains moderate, this proof-of-principle demonstrates a sustainable and cost-effective enzymatic route for indigo production from biobased starting materials, providing an environmentally friendly alternative to petrochemical synthesis.

Indexed as

Indigo CarmineIndolesTryptophanBiocatalysisMixed Function OxygenasesTryptophanaseIndigo CarmineindoleIndolesMixed Function OxygenasesTryptophanTryptophanasebiocatalysisenzyme cascadeindigoL‐tryptophanperoxygenase

Identifiers

PMID42011133
PMCPMC13096859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.